|
| Tuesday, September 2, 2025 |
|
|
沙利文第十九屆全球增長、科創與領導力峰會順利閉幕 |
| 由弗若斯特沙利文（Frost & Sullivan，簡稱："沙利文"）主辦，頭豹協辦的2025第十九屆沙利文全球增長、科創與領導力峰會暨第四屆新投資大會（以下簡稱"2025沙利文新投資大會"或"大會"）在上海靜安香格里拉酒店成功舉辦。 more info >> |
|
| Monday, September 1, 2025 |
|
|
沙利文第十九届全球增长、科创与领导力峰会顺利闭幕 |
| 由弗若斯特沙利文（Frost & Sullivan，简称："沙利文"）主办，头豹协办的2025第十九届沙利文全球增长、科创与领导力峰会暨第四届新投资大会（以下简称"2025沙利文新投资大会"或"大会"）在上海静安香格里拉酒店成功举办。 more info >> |
|
| Tuesday, September 3, 2024 |
|
|
The 18th Frost & Sullivan Growth, Innovation and Leadership Summit, China: A Huge Success |
| The 18th Frost & Sullivan Growth, Innovation and Leadership Summit and the 3rd New Investment Event (NIE 2024), was held in Shanghai from August 27-30, 2024, co-hosted by LeadLeo. more info >> |
|
|
2024沙利文新投資大會圓滿閉幕：凝新聚力，質贏未來 |
| 由弗若斯特沙利文（Frost & Sullivan，簡稱：“沙利文”）主辦，頭豹協辦的2024第十八届沙利文中國增長、科創與領導力峰會暨第三届新投資大會於8月28日-8月30日在上海靜安瑞吉酒店成功舉辦。 more info >> |
|
|
2024沙利文新投资大会圆满闭幕：凝新聚力，质赢未来 |
| 由弗若斯特沙利文（Frost & Sullivan，简称：“沙利文”）主办，头豹协办的2024第十八届沙利文中国增长、科创与领导力峰会暨第三届新投资大会于8月28日-8月30日在上海静安瑞吉酒店成功举办。 more info >> |
|
| Wednesday, July 8, 2020 |
|
|
Frost & Sullivan Honors Leading Organizations in Asia-Pacific in an Inaugural Virtual Ceremony for the 2020 Asia-Pacific Best Practices Awards |
| Frost & Sullivan honored Asia-Pacific's leading companies at the 18th annual Asia-Pacific Best Practices Awards on 8 July in an inaugural virtual awards ceremony. more info >> |
|
| Friday, March 3, 2017 |
|
|
Frost＆Sullivan的最新研究顯示亞洲是臨床試驗的首選地 |
Frost＆Sullivan今天發布了其與亞太專家CRO Novotech合作的最新白皮書“亞洲：臨床試驗的首選地”。新白皮書的研究表明，由於擁有大量無治療效果的患者庫，特殊的臨床基礎設施和人才，以及較低的運營成本，亞洲正迅速成為臨床研究的主力軍。
more info >> |
|
|
Frost＆Sullivan的最新研究显示亚洲是临床试验的首选地 |
Frost＆Sullivan今天发布了其与亚太专家CRO Novotech合作的最新白皮书“亚洲：临床试验的首选地”。新白皮书的研究表明，由于拥有大量无治疗效果的患者库，特殊的临床基础设施和人才，以及较低的运营成本，亚洲正迅速成为临床研究的主力军。
more info >> |
|
|
New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials |
| Frost & Sullivan released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific specialist CRO Novotech. Research from the new white paper revealed Asia is quickly becoming a clinical research powerhouse. more info >> |
|
| Wednesday, June 25, 2014 |
|
|
Fast-Evolving US Cardiac Ablation Industry Affords Multiplying Niche Opportunities, Says Frost & Sullivan |
| Recent analysis from Frost & Sullivan's Analysis of the US Cardiac Ablation Market finds the market earned revenue of $2.77 billion in 2013 and estimates this to reach $5.75 billion in 2020. The analysis covers catheter ablation, surgical ablation and cardiac mapping. more info >> |
|
|
|
|
